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F
ucosylation is essential for proper cell signaling and embryo-
nic development. For example, the Notch receptor must be
fucosylated for Notch signaling, which regulates stem cell fate
decisions and organogenesis.
13 Fucose also resides at the
periphery of N- and O-glycans in structures such as Lewis x, an
epitopealsoknownasstage-speciﬁcembryonicantigen1(SSEA-
1) that is found in mouse early embryogenesis.
4,5 Lewis x is also
present in the developing brain, where it is thought to be
important for cellcell interactions.
4,6,7 In zebraﬁsh, a mutant
that is deﬁcient in the de novo biosynthetic pathway for fucose
exhibits neural migration defects.
8 Mouse knockouts of fucose
biosynthetic genes and fucosyltransferases have demonstrated
that the sugar is necessary for diverse aspects of embryogenesis,
organogenesis, and neurogenesis.
2,912 However, determining
theactualfunctionsoffucosylationduringtheseprocesseswould
beneﬁt from an ability to analyze the fucose modiﬁcation in a
living organism.
Herewereportamethodforimagingfucosylatedglycansinvivo.
We chose the zebraﬁsh as our model organism due to its well-
deﬁned developmental program, optically transparent embryos,
and ease of microinjection with exogenous reagents.
13 We applied
the bioorthogonal chemical reporter strategy
14 for fucose labeling,
whichwehavepreviouslyusedtoimagesialicacidsandmucin-type
O-glycans in developing zebraﬁsh.
15,16 In this strategy, azide-
functionalized monosaccharides are incorporated into cell-surface
glycans via the cells’ own metabolic machinery. The azide is
subsequently reacted with an imaging probe or pull-down reagent
via copper-free click chemistry.
17
Speciﬁcally,weutilizedseveralanaloguesoffucosemodiﬁedat
the C6-position with an azide (FucAz, Figure 1). In mammalian
cell culture, FucAz traverses endogenous metabolic pathways
andisincorporatedintocell-surfaceglycans.
18,19FucAzisutilized
by the fucose salvage pathway, where it is ﬁrst converted to
FucAz-1-phosphate (FucAz-1-P) by fucose kinase (FUK) and
then to GDP-FucAz by fucose-1-phosphate guanyltransferase
(FPGT) (Figure 1). GDP-FucAz is transported into the Golgi
apparatus, where it serves as a substrate for fucosyltransferases
(FucTs)thatinstallFucAzontoglycoproteins.Atthecellsurface,
the azide-labeled glycans can be imaged via reaction with a
diﬂuorinated cyclooctyne reagent conjugated to Alexa Fluor 488
(DIFO-488).
20
Forthisstrategytobefeasibleinzebraﬁsh,thesalvagepathway
andfucosyltransferaseenzymesmustbeexpressedintheembryo.
The fucose salvage pathway, which is present in mammals but
absentfromDrosophila,
21hasnotbeencharacterizedinzebraﬁsh,
although salvage pathway candidate genes are registered in
GenBank (accession numbers XP_001344272 and NP_0010-
18590). The zebraﬁsh mutant that is deﬁcient in the de novo
biosynthetic pathway for fucose retains the ability to fucosylate
Notch, but its neural migration defect at 48 h postfertilization
(hpf) is not rescued by injection of fucose.
8 These observations
suggest that fucose salvage occurs during early embryogenesis
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ABSTRACT: Many developmental processes depend on
proper fucosylation, but this post-translational modiﬁcation is
diﬃculttomonitorinvivo.Hereweappliedachemicalreporter
strategy to visualize fucosylated glycans in developing zebra-
ﬁsh. Using azide-derivatized analogues of fucose, we metabo-
lically labeled cell-surface glycans and then detected the
incorporated azides via copper-free click chemistry with a
diﬂuorinated cyclooctyne probe. We found that the fucose
salvage pathway enzymes are expressed during zebraﬁsh embryogenesis but that they process the azide-modiﬁed substrates
ineﬃciently.Wewereabletobypassthesalvagepathwaybyusinganazide-functionalizedanalogueofGDP-fucose.Thisnucleotide
sugarwasreadilyacceptedbyfucosyltransferasesandprovidedrobustcell-surfacelabelingoffucosylatedglycans,asdeterminedby
ﬂow cytometry and confocal microscopy analysis. We used this technique to image fucosylated glycans in the enveloping layer of
zebraﬁsh embryos during the ﬁrst 5 days of development. This work provides a method to study the biosynthesis of fucosylated
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but perhaps at very low levels. Indeed, in mammalian cell lines,
fucose salvage has been shown to account for only 10% of total
fucosylation.
22
We began our analysis by directly analyzing the expression of
fucose salvage pathway enzymes. We used RT-PCR to detect
mRNA transcripts at several stages of development (Figure 2).
We found that both salvage pathway enzymes, FUK and FPGT,
had detectable transcripts at the 1632-cell stage, before zygotic
transcription begins,
23 indicating that these transcripts are pro-
vided maternally. Zygotic expression of FUK and FPGT was
detectable after midsegmentation stages. In contrast, transcripts
for GDP-mannose 4,6-dehydratase (GMDS), a key enzyme in
the de novo biosynthesis of GDP-fucose,
24 were detected at all of
the stages tested. Transcripts of the Golgi GDP-fucose transpor-
ter GFT were found at all stages as well.
We also examined the expression of putative fucosyltransfer-
ase genes that are predicted from genome analysis.
8 The corre-
spondingenzymesareclassiﬁedonthebasisofthetypeoffucosyl
linkage that they are predicted to generate. The protein
O-fucosyltransferases POFUT1 and POFUT2, which catalyze the
additionoffucosetothehydroxylgroupsofserineandthreonine
residues, were expressed at all of the stages tested. The former
is required for Notch signaling,
2 and the latter fucosylates
thrombospondin type I repeats found in many extracellular
matrixproteinsfromCaenorhabditiseleganstohumans.
25Among
the predicted R1,3-fucosyltransferases, which catalyze the addi-
tionoffucosetoterminalglycanstructuressuchasLewisx,FUT9
wasexpressedatallofthestagestested,andFUT7wasexpressed
from 6 hpf onward. These results are consistent with existing
insituexpressiondataforPOFUT1andFUT9.
26Twoadditional
R1,3-fucosyltransferases in zebraﬁsh, FT1 and FT2, have been
shown to synthesize Lewis x in vitro and are expressed only at
1518 and 72 hpf, respectively.
27 Additionally, the predicted
core N-glycan R1,3-fucosyltransferase FUT10 was expressed at
allofthe stagestested, andtranscriptsofthecore N-glycan R1,6-
fucosyltransferaseFUT8weredetectedfrom15hpfonward.The
presence of these transcripts, along with those of the salvage
pathway and de novo biosynthetic enzymes, suggests that fuco-
sylated glycans are synthesized during early development and
that the necessary machinery for metabolic labeling is present.
Encouraged by these expression data, we attempted to label
fucosylated glycans by treatment with FucAz. We bathed em-
bryos in medium containing cell-permeable, per-O-acetylated
FucAz for 2 days and then reacted the embryos with DIFO-488
to visualize FucAz that had been incorporated into cell-surface
glycans. However, these embryos exhibited no azide-dependent
cell-surface labeling (Supplementary Figure 1).
This result suggested that one of the proteins in the biosyn-
thetic pathway might not accept the unnatural azide-modiﬁed
substrate.BecausehumanFucTs cantolerate largemodiﬁcations
at the C6 position of fucose,
28,29 we suspected that one of the
salvage pathway enzymes or the Golgi GDP-fucose transporter
formed a bottleneck. We therefore sought to systematically
bypass enzymes in the pathway by metabolic labeling with the
downstream intermediates FucAz-1-P and GDP-FucAz. Because
these reagents are not cell-permeable, we microinjected them
into the yolk of 18-cell zebraﬁsh embryos. At this stage, small
moleculesinjectedintotheyolkaretakenupintotheﬁrstcellsof
the organism and subsequently distributed to all of the daughter
cells over the course of development.
30,16
We previously demonstrated that microinjection of zebra-
ﬁsh embryos with other azidosugars followed by reaction with
DIFO-488enablesﬂuorescenceimagingofcell-surfaceglycansin
the enveloping layer.
16 Using a similar method, embryos were
microinjected withFucAz-1-P,GDP-FucAz,orvehiclealoneand
Figure 1. Pathway for metabolic labeling of fucosylated glycans using 6-azido fucose (FucAz). In the fucose salvage pathway, FucAz is converted to
FucAz-1-phosphate (FucAz-1-P) and then to GDP-FucAz by the sequential actions of fucose kinase (FUK) and fucose-1-phosphate guanyltransferase
(FPGT). GDP-FucAz is then transported into the Golgi lumen by the GDP-fucose transporter (GFT). Within the Golgi compartment,
fucosyltransferases (FucTs) add FucAz to glycoproteins, which are then exported to the cell surface or secreted. To image FucAz incorporated into
cell-surface glycans, the azide is reacted with an Alexa Fluor 488 conjugate of DIFO (DIFO-488).
Figure 2. Expression of fucosylation pathway proteins during zebraﬁsh
embryogenesis. Transcripts were detected by RT-PCR analysis at
various developmental stages (hpf, hours postfertilization). FUK,
fucose kinase; FPGT, fucose-1-phosphate guanyltransferase; GMDS,
GDP-mannose 4,6-dehydratase; GFT, Golgi GDP-fucose transporter;
POFUT1 and 2, protein O-fucosyltransferases; FUT710, various
fucosyltransferases.549 dx.doi.org/10.1021/cb100284d |ACS Chem. Biol. 2011, 6, 547–552
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wereallowedtodevelopfor10h.Theembryoswerethenbathed
in a solution of DIFO-488 to react with azide-labeled glycans in
the enveloping layer and imaged by confocal microscopy.
We observed robust cell-surface DIFO-488 ﬂuorescence in the
enveloping layer of embryos injected with GDP-FucAz and no
detectable signal from embryos injected with vehicle alone
(Figure 3, panel a, top). This result is consistent with a recent
report of metabolic labeling using an alkynyl derivative of fucose.
31
E m b r y o si n j e c t e dw i t hF u c A z - 1 - Pd i s p l a y e dw e a kc e l l - s u r f a c e
ﬂuorescence that was detectable only using higher laser power
and detector gain (Figure 3, panel a, bottom). This result suggests
that conversion of FucAz-1-P to GDP-FucAz is ineﬃcient in
zebraﬁsh. Even when the FucAz-1-P-injected embryos were al-
lowed to develop for 24120 hpf before reaction with DIFO-488,
negligible cell-surface ﬂuorescence was observed (Supplementary
Figure 2). This observation contrasts with the relatively eﬃcient
enzymatic conversion of azide-modiﬁed sialic acid precursors to
sialosides in mammalian systems.
32
ForamorequantitativecomparisonoftheeﬃcienciesofFucAz-
1-P and GDP-FucAz metabolism, we analyzed cells from meta-
bolicallylabeledandthendissociatedzebraﬁshembryosusingﬂow
cytometry. Embryos were microinjected with FucAz-1-P, GDP-
FucAz, or vehicle alone and were then allowed to develop to 15
hpf.TheembryoswereincubatedwiththeN-hydroxysuccinimidyl
esterofAlexaFluor488(NHS-488),achargeddyethatreactswith
amines on the organism’s surface, to speciﬁcally label cells of the
envelopinglayer.Theembryoswerethendissociatedbytreatment
withethylenediaminetetraaceticacid(EDTA),thecellsuspension
was labeledwithDIFO-biotinfollowed by avidin-allophycocyanin
(avidin-APC), and cellular ﬂuorescence was quantiﬁed by ﬂow
cytometry.
Enveloping layer cells (identiﬁed by their high NHS-488
ﬂuorescence)fromGDP-FucAz-injectedembryosdisplayedover
7-foldhigher avidin-APCsignalthancells fromembryosinjected
with FucAz-1-P or vehicle alone (Figure 3, panel b, left). This
result is consistent with the imaging analysis of the enveloping
layer. Cells from the interior of the organism (identiﬁed by their
low NHS-488 ﬂuorescence) also exhibited avidin-APC signal
that was higher in GDP-FucAz-injected embryos than in FucAz-
1-P- or vehicle-injected embryos (Figure 3, panel b, right). This
observation indicates that internal cells also incorporate FucAz
intotheirglycansby15hpf,althoughapparentlytoalesserextent
than enveloping layer cells (Figure 3, panel c). However, a direct
comparison of enveloping layer and internal cells by ﬂow
cytometry is diﬃcult because the analysis involves a heteroge-
neouspopulationwithdiﬀerentcelltypes,sizes,andgranularities.
The ability of GDP-FucAz tolabel fucosylated glycans implies
that this unnatural substrate enters the Golgi lumen and is
utilized by fucosyltransferase enzymes. Although the mechanism
of entry into the secretory pathway is unknown, it is expected to
Figure 3. GDP-FucAz metabolically labels cell-surface glycans of the enveloping layer more eﬃciently than FucAz-1-P. (a) Fluorescence images of
embryos microinjected with GDP-FucAz or FucAz-1-P. Zebraﬁsh embryos were microinjected with 75 pmol of GDP-FucAz, FucAz-1-P, or vehicle
alone, allowed to develop to 10 hpf, and reacted with DIFO-488. Shown are z-projection images of DIFO-488 ﬂuorescence in the enveloping layer
(EVL). Top: laser and detector gain settings optimized for ﬂuorescence of GDP-FucAz-treated embryos. Bottom: laser and detector gain settings
optimized for ﬂuorescence of FucAz-1-P-treated embryos. Scale bar: 200 μm. (b) Flow cytometry analysis of EVL and internal cells after metabolic and
chemical labeling. Zebraﬁsh embryos were microinjected with 75 pmol of the indicated sugar and allowed to develop to 15 hpf. Cells of the EVL were
labeled withNHS-488. Theembryos weredissociated, and theresulting cellsuspension was reacted withDIFO-biotin, incubatedwith avidin-APC, and
analyzed by ﬂow cytometry. Error bars represent standard error for three replicates. c) FucAz labeling is most pronounced on EVL cells (detected with
NHS-488). Shown are representative ﬂow cytometry plots corresponding to data shown in panel b. Each plot includes at least 50,000 cells. Numbers in
the corners of quadrants represent the percent of total.550 dx.doi.org/10.1021/cb100284d |ACS Chem. Biol. 2011, 6, 547–552
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occur via active transport by the Golgi GDP-fucose transporter
GFT.
33 We sought to determine whether GDP-FucAz labeling
was dependent on GFT expression. Using a translation-blocking
morpholinooligonucleotide,wesuppressedGFTexpressionand
observed no decrease in DIFO-derived signal in embryos in-
jected with the GFT morpholino compared to control embryos
(SupplementaryFigure3).Thisresultsuggeststhattheremaybe
a second GDP-fucose transporter in zebraﬁsh. Indeed, the
zebraﬁsh genome contains a homologue of Slc35c2, which has
been proposed in recent studies to be a second GDP-fucose
transporter in mammalian cells.
34
The lack of labeling by FucAz-1-P, in contrast to the robust
labeling with GDP-FucAz, suggests that the salvage pathway
enzyme FPGT does not tolerate the 6-azido modiﬁcation. Indeed,
human FPGT is 160-fold less eﬃcient when using an analogue of
fucose extended at the C6 position by a methyl group as a
substrate.
35 This observation may also explain the weak labeling
by FucAz in cultured mammalian cells.
18,19 Alternatively, although
RT-PCR analysis showed that transcripts for the salvage pathway
enzymes were present, this method is not quantitative, and it is
possible that salvage pathway enzyme levels were not high enough
to yield eﬃcient labeling. Notably, FucAz is toxic to mammalian
cells in culture;
18 however, we did not observe any adverse eﬀects
on zebraﬁsh embryos during incubation with 5 mM per-O-acety-
lated FucAz in the medium or after microinjection of up to
125 pmol of FucAz-1-P or GDP-FucAz.
We used GDP-FucAz as a metabolic substrate to determine the
onset and extent of fucose labeling during early development.
Embryos were microinjected with GDP-FucAz or vehicle alone,
then reacted with DIFO-488, and imaged at several stages of
development. Cell-surface labeling of the enveloping layer was
observed as early as 65% epiboly, or 7 hpf (Supplementary
Figure 4). The labeling intensity increased from midgastrulation
to early segmentation periods (Figure 4). These dynamics are
similartothoseobservedforexpressionofmucin-typeO-glycans
16
and N-glycans,
36 both of which can be modiﬁed by fucosylation.
FluorescencederivedfromFucAz-labeledglycansintheenveloping
layer decreased from 24 hpf onward (Figure 4). This decrease in
signal could be due to depletion or degradation of the GDP-FucAz
substrate, or it could reﬂect decreasing levels of endogenous
fucosylation. Indeed, labeling of fucosylated glycans in the envel-
opinglayerbythefucose-bindingAleuriaaurantialectin(AAL)also
decreased from 12 to 24 hpf, as determined by ﬂow cytometry
analysis (Supplementary Figure 5). Nevertheless, signal from
FucAz-labeled glycans remained strong enough to observe
FucAz-dependent signal over the ﬁrst 5 days of development.
During these studies we observed no toxicity or developmen-
tal defects due to FucAz incorporation into zebraﬁsh glycans.
This may suggest that the azide modiﬁcation does not interfere
with the normal functionality of fucosylated glycans or that
FucAz replaces a small enough fraction of natural fucose that
its biological eﬀects are indiscernible. The eﬃciency of the
subsequent reaction of cell-surface azides with DIFO-488 is
enhanced by the intrinsically high bimolecular rate constant of
copper-free click chemistry
20 and the molar excess of DIFO
utilized in these experiments. Thus, metabolic labeling with
FucAz followed by copper-free click chemistry is an eﬀective
and nontoxic method for imaging fucosylated glycans in vivo.
In conclusion, we have successfully applied the chemical
reporter strategy to enable visualization of fucosylation during
zebraﬁsh development. During these studies, we discovered that
the fucose salvage pathway is expressed in zebraﬁsh embryos but
does not process azide-modiﬁed substrates eﬃciently. In con-
trast, fucosyltransferase enzymes readily utilize GDP-FucAz,
thereby incorporating the azide into newly synthesized glyco-
conjugates. In addition to its use in imaging applications, the
azide modiﬁcation can be exploited for isolation and identiﬁca-
tion of fucosylated glycoproteins during development.
’METHODS
Metabolic Labeling of Zebrafish by Microinjection of
GDP-FucAz and FucAz-1-P. Zebrafish embryos at the 18-cell stage
weremicroinjectedintotheyolkwith15nLof25or50mMsolutionsof
GDP-FucAz,FucAz-1-P,ornosugar(fordosesof75125pmol) in0.2M
KCl, with rhodamine-dextran (5% w/v) or phenol red (0.05% w/v) as
tracerdyes.Oncetheembryosdevelopedto4hpf,theywereenzymatically
dechorionated by incubating for 10 min in a 1 mg mL
1 solution of
Figure 4. Microinjection of GDP-FucAz followed by copper-free click chemistry enables imaging of fucosylated glycans during the ﬁrst 5 days of
development.Zebraﬁshembryosweremicroinjectedwithvehiclealone(top)or75pmolofGDP-FucAz(bottom),allowedtodevelop,thentreatedwith
DIFO-488, and imaged at the time indicated. Shown are z-projection DIFO-488 ﬂuorescence images of the EVL (rows 1 and 3) and corresponding
brightﬁeld images (rows 2 and 4). Scale bar: 200 μm.551 dx.doi.org/10.1021/cb100284d |ACS Chem. Biol. 2011, 6, 547–552
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pronasein embryo medium(150 mM NaCl, 0.5mMKCl,1.0 mM CaCl2,
0.37 mM KH2PO4,0 . 0 5m MN a 2HPO4,2 . 0m MM g S O 4,0 . 7 1m M
NaHCO3 in deionized water, pH 7.4). All embryos younger than 12 hpf
were maintained in 1% agarose-coated dishes. Embryos older than 24 hpf
were incubated in embryo medium containing 131 μM N-phenylthiourea
(PTU) to inhibit melanin production.
Detection of Cell-Surface Glycans by Copper-Free Click
ChemistryandConfocalMicroscopy.Embryoswerereactedwith
100 μM DIFO-488 in embryo medium for 1 h at 28.5  C. The embryos
wererinsedbytransferthroughsixsuccessive15-cmtissueculturedishes
containing embryo medium. For imaging by confocal microscopy, the
embryosweremountedbetweentwocoverslipsinasolutionof0.6%low
meltingpointagaroseinembryomedium.Forembryos24hpfandolder,
2.6 μM tricaine (ethyl 3-aminobenzoate methanesulfonate) was in-
cluded in the medium and agarose for mounting.
Flow Cytometry of Zebrafish Embryos. Zebrafish embryos
were microinjected with 75 pmol of the indicated sugar and phenol red
asdescribed.At15hpf,theembryoswerereactedwithNHS-488(50μM
in embryo medium with 1% DMSO) for 30 min at 28.5  C. After this
reaction, the embryos were rinsed four times in embryo medium and
were transferred to calcium-free Ringer’s solution (116 mM NaCl,
2.6 mM KCl, 5 mM HEPES in deionized water, pH 7.0) and deyolked
by passage through a 200-μL pipet tip. The embryos were then
incubated for 15 min at 28.5  C in a solution of 5 mM EDTA in
phosphate-buffered saline (PBS), pH 7.6, to dissociate the cells. The
reaction was stopped by the addition of 5% fetal bovine serum (FBS)
and1 mMCaCl2in PBS.Thecells wererinsedoncewith labelingbuffer
(PBS, pH 7.6, 1% FBS). The cell suspension was reacted with DIFO-
biotin (100 μM in labeling buffer) for 30 min at 28.5  C. Following this
reaction, the cells were rinsed once with labeling buffer and then
incubated with avidin-APC (50 μg/mL in labeling buffer) for 15 min
on ice. The cells were then rinsed and reacted a second time for 30 min
with avidin-APC.Thecells werewashedthree timesandresuspendedin
300 μL of labeling buffer and passed through a 35-μm filter before
analysis by flow cytometry.
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